P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
about
Exposure to carbon nanotubes leads to changes in the cellular biomechanicsCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Cancer stem cells and drug resistance: the potential of nanomedicineImmunomodulation of nanoparticles in nanomedicine applicationsEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Carbon nanotubes as cancer therapeutic carriers and mediatorsSurface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicityAltered cell mechanics from the inside: dispersed single wall carbon nanotubes integrate with and restructure actinPluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injuryReducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel NanoconjugatesNon-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systemspH-sensitive nanocargo based on smart polymer functionalized graphene oxide for site-specific drug delivery.Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.A new era of cancer treatment: carbon nanotubes as drug delivery tools.Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs.A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapyEnhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Self-assembled Multifunctional DNA Nanoflowers for the Circumvention of Multidrug Resistance in Targeted Anticancer Drug Delivery.Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.Effect of nitrogen atomic percentage on N+-bombarded MWCNTs in cytocompatibility and hemocompatibilityTargeting carbon nanotubes against cancer.Carbon nanotubes: applications in pharmacy and medicine.Nanomaterials for targeted drug delivery to cancer stem cells.Stimuli-responsive cancer therapy based on nanoparticles.Carbon nanotubes: potential medical applications and safety concerns.Advances in the biomedical application of polymer-functionalized carbon nanotubes.Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.Carbon Nanotubes Disrupt Iron Homeostasis and Induce Anemia of Inflammation through Inflammatory Pathway as a Secondary Effect Distant to Their Portal-of-Entry.Carbon nanotubes in cancer therapy and drug delivery.Carbon nanotubes: a novel material for multifaceted applications in human healthcare.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Synthesis and evaluation of single-wall carbon nanotube-paclitaxel-folic acid conjugate as an anti-cancer targeting agent.Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study.Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding.Therapeutics formulated to target cancer stem cells: Is it in our future?
P2860
Q23911034-F5735F38-56FB-4466-A4DE-82F586896E13Q26830028-60D42CD3-0989-40C9-AC38-97466D8A40C6Q26998993-94065E4F-5AD3-47E5-8A55-64600E993E5EQ27021145-9C4C72CE-897B-4947-8927-81DBC70FBD1CQ28073956-15AFF379-C2CD-4456-937F-8DC36D627655Q28074309-0F73C7B2-7519-474A-93F7-7651EF76EC6FQ28385356-BD5CD1B8-ACFC-4433-B20D-302970C65433Q28387306-CDB3EF65-515A-45FC-B385-0E3E5FA75640Q28392985-652FDBDE-963B-4F89-9E6C-5B83DADFCF1BQ28553214-AD346A3A-3F83-4B02-A023-AE0DFE5B4023Q28822460-7AC35539-52EA-414E-99A3-E275E4E169AFQ30596446-A08C1970-F64E-434C-8DF5-D52F25025FB6Q34011106-1AAAB091-52F0-407A-A62A-A3912AC7BC73Q34033804-322E2EEC-467E-47A6-B58C-7BF1B5C5457EQ34097540-7D8D9975-5888-4F5C-817A-081B969A897FQ34473476-4C5FD191-7002-47F2-A2B4-A8E707100B60Q34977497-E2CD8CDE-EEA7-4B44-866E-C0F24D02B939Q35574213-DE2BB89E-2D8E-48B8-9B5C-CF633A0DD908Q35918956-62DA9ECF-2AB1-4114-BA81-62BD67564E15Q37031597-0991548C-6A88-4DC5-839B-7C43D103F2E7Q37351040-E15B61B4-8AEC-4DB0-A439-42325D48439EQ37404658-99CFE425-EF04-4238-90E8-A41AEBFF2109Q37703417-532D4EE8-0754-4F08-BA5F-7327A312BD61Q37994689-AFA71B04-00AE-4C55-84D4-B8020FD480EEQ38160231-27054DE5-C8E5-4687-A543-F171BBE01C2EQ38201740-FFE7705D-A1E6-483B-8CD6-7070F6F770ACQ38233457-57079837-FD8B-4A7E-B3A7-F197C4096D42Q38272075-EEA4AC8A-F8E1-4C8D-AAF7-637911B70C5CQ38556891-5381C21E-D408-4A94-9964-1D6ADBA40C42Q38707907-74C25F3D-AC96-44A5-B0C8-FB3D9EDD59BDQ38757812-2ECF357C-3739-4101-B7E2-4A17C1F55705Q38790433-F04FF61D-C998-471E-8F02-9483508E54BCQ38795672-6CCE6687-5FE3-47D9-94FF-97F89385709EQ38809044-8A02DFA2-F4F7-4C72-8741-D36A1BA7599AQ38898321-862CB923-E9C4-401C-94B4-3E0B1A0C520FQ39170794-1ADCB60F-BAB0-402A-9EE5-6ADF7D19B526Q39567982-2DB3D51D-D23B-43E8-AC6B-B9F7783DEB65Q39639787-2A2964E8-926E-46C0-A4B9-29F9F4942A11Q39747061-9E001F60-3CDA-4E2C-8788-53D4E1EC610AQ39767667-F4D9E007-B0BC-466A-9650-3A4F1AE1DCC2
P2860
P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@ast
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@en
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@nl
type
label
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@ast
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@en
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@nl
prefLabel
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@ast
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@en
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@nl
P2093
P921
P356
P1433
P1476
P-glycoprotein antibody functi ...... tance of human leukemia cells.
@en
P2093
P304
P356
10.1021/NN9011225
P407
P577
2010-03-01T00:00:00Z